Cardiatis

Peripheral aneurysms are rare but when they happen they have very serious consequences. Popliteal artery aneurysms are the most common peripheral artery aneurysms accounting for over 80% of the total aneurysms in the periphery.

At the time of presentation, approximately 75% of peripheral artery aneurysms are symptomatic. Traditionally, larger aneurysms have been believed to be more likely than smaller aneurysms to produce symptoms, but this has recently been questioned.

Aneurysm size plays less of a role in the decision to treat peripheral artery aneurysms compared to aneurysms in other locations such as the aorta or the brain. This is because the major morbidity from peripheral aneurysms is due to thromboembolism rather than rupture and these aneurysms require repair regardless of size.

Surgery is the current gold standard in treating peripheral aneurysms, however Cardiatis FluidSmart stent technology platform offers a viable endovascular alternative in difficult to operate cases.

Cardiatis 3D multilayer fluid modulating stents have already been deployed, with successful results, in several peripheral aneurysms ranging from the popliteal to the renal.